4
Changes in Ownership
Aldeyra Therapeutics, Inc. Filed Acc 0000904454-14-000410
10% owner acquired 72,690 shares (option exercise)
- 10% owner gave up 46,876 shares (to pay taxes)
- 10% owner acquired 1,724,478 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
JOHNSON & JOHNSON · 10% owner
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2014-05-01 | Conversion : show line 1 in the form | +1,724,478 | 1,724,478 | I | ||
| 2014-05-01 | Exercise or conversion : show line 2 in the form | +36,345 | $5.16 | $187,540 | 1,760,823 | I |
| 2014-05-01 | Shares withheld for taxes : show line 3 in the form | −23,438 | $8.00 | $187,504 | 1,737,385 | I |
| 2014-05-01 | Exercise or conversion : show line 4 in the form | +36,345 | $5.16 | $187,540 | 1,773,730 | I |
| 2014-05-01 | Shares withheld for taxes : show line 5 in the form | −23,438 | $8.00 | $187,504 | 1,750,292 | I |
Table II: Derivative
6 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2014-05-01 | Conversion : show line 6 in the form Series A Preferred Stock | −385,800 | 0 | I |
| 2014-05-01 | Conversion : show line 7 in the form Non-Voting Series A Preferred Stock | −104,396 | 0 | I |
| 2014-05-01 | Conversion : show line 8 in the form Series B Preferred Stock | −427,591 | 0 | I |
| 2014-05-01 | Conversion : show line 9 in the form Non-Voting Series B Preferred Stock | −133,827 | 0 | I |
| 2014-05-01 | Exercise or conversion : show line 10 in the form Series B Preferred Stock Warrant (Right to Buy) | −36,345 | 0 | I |
| 2014-05-01 | Exercise or conversion : show line 11 in the form Series B Preferred Stock Warrant (Right to Buy) | −36,345 | 0 | I |
Loading xslF345X03/edgar.xml…